SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Codivilla A 1905 On the means of lengthening in the lower limbs. Am J Orthop Surg 2: 353369.
  • 2
    Ilizarov G 1990 Clinical application of the tension-stress effect for limb lengthening. Clin Orthop 250: 826.
  • 3
    Isefuko S, Joyner CJ, Simpson HRW 2000 A murine model of distraction osteogenesis. Bone 27: 661665.
  • 4
    Tay BK, Le AX, Gould SE, Helms JA 1998 Histochemical and molecular analysis of distraction osteogenesis in a mouse model. J Orthop Res 16: 636642.
  • 5
    Aronson J, Hogue WR, Flahiff CM, Gao GG, Shen XC, Skinner RA, Badger TM, Lumpkin CK Jr 2001 Development of tensile strength during distraction osteogenesis in a rat model. J Orthop Res 19: 6469.
  • 6
    Sato M, Ochi T, Nakase T, Hirota S, Kitamura Y, Nomura S, Yasui N 1999 Mechanical tension-stress induces expression of bone morphogenetic protein (BMP)-2 and BMP-4, but not BMP-6, BMP-7, and GDF-5 mRNA, during distraction osteogenesis. J Bone Miner Res 14: 10841095.
  • 7
    Li G, Simpson AH, Kenwright J, Triffitt JT 1999 Effect of lengthening rate on angiogenesis during distraction osteogenesis. J Orthop Res 17: 362367.
  • 8
    Lewinson D, Maor G, Rozen N, Rabinovich I, Stahl S, Rachmiel A 2001 Expression of vascular antigens by bone cells during bone regeneration in a membranous bone distraction system. Histochem Cell Biol 116: 381388.
  • 9
    Meyer U, Meyer T, Wiesman HP, Kruse-Losler B, Vollmer D, Stratmann U, Joos U 2001 Mechanical tension in distraction osteogenesis regulates chondrocytic differentiation. Int J Oral Maxillo Surg 30: 522530.
  • 10
    Aronson J, Harp JH, Walker CW, Dalrymple GV 1990 Blood flow, bone formation and mineralization during distraction osteogenesis. Trans Orthop Res Soc 15: 589594.
  • 11
    Pacicca DM, Patel N, Lee C, Salisbury K, Lehmann W, Carvalho R, Gerstenfeld LC, Einhorn TA 2003 Expression of angiogenic factors during distraction osteogenesis. Bone 33: 889898.
  • 12
    Carvalho RS, Einhorn TA, Lehmann W, Edgar C, Al-Yamani A, Apazidis A, Pacicca D, Clemens TL, Gerstenfeld LC 2004 The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone 34: 849861.
  • 13
    Lehmann W, Edgar CM, Wang K, Cho TJ, Barnes GL, Kakar S, Graves DT, Rueger JM, Gerstenfeld LC, Einhorn TA 2005 Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone 36: 300310.
  • 14
    Maes C, Coenegrachts L, Stockmans I, Daci E, Luttun A, Petryk A, Gopalakrishnan R, Moermans K, Smets N, Verfaillie CM, Carmeliet P, Bouillon R, Carmeliet G 2006 Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 116: 12301242.
  • 15
    Street J, Bao M, de Guzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH 2002 Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99: 96569661.
  • 16
    Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin DJ 1999 Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res 59: 52095218.
  • 17
    Witte L, Hicklin DJ, Zhu Z, Pytowski B, Kotanides H, Rockwell P, Bohlen P 1998 Monoclonal antibodies targeting the VEGF receptor-2 (Flk-1/KDR) as an anti-angiogenic therapeutic strategy. Cancer Metastasis Rev 17: 155161.
  • 18
    Carano RA, Filvaroff EH 2003 Angiogenesis and bone repair. Drug Discov Today 8: 980989.
  • 19
    Wang ES, Teruya-Feldstein J, Wu Y, Zhu Z, Hicklin DJ, Moore MA 2004 Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo. Blood 104: 28932902.
  • 20
    Gerstenfeld LC, Cho T-J, Kon T, Aizawa T, Tsay A, Barnes GL, Graves DT, Einhorn TA 2003 Impaired fracture healing in the absence of TNF-α signaling: The role of TNF-α in endochondral cartilage resorption. J Bone Miner Res 18: 15841592.
  • 21
    Wang K, Vishwanath P, Eichler GS, Al-Sebaei MO, Edgar CM, Einhorn TA, Smith TF, Gerstenfeld LC 2005 Analysis of fracture healing by large scale transcriptional profile identified temporal relationships between metalloproteinase and ADAMTS mRNA expression. Matrix Biol 25: 271281.
  • 22
    Duvall CL, Robert Taylor W, Weiss D, Guldberg RE 2004 Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. Am J Physiol Heart Circ Physiol 287: H302H310.
  • 23
    Shefelbine SJ, Simon U, Claes L, Gold A, Gabet Y, Bab I, Muller R, Augat P 2005 Prediction of fracture callus mechanical properties using microCT images and voxel-based finite element analysis. Bone 36: 480488.
  • 24
    Gerstenfeld LC, Alkhiary YM, Krall EA, Nicholls FH, Stapleton SN, Fitch JL, Graves DT, Jepsen KJ, Einhorn TA 2006 Three dimensional reconstruction of fracture callus morphogenesis demonstrates asymmetry in callus development. J Histochem Cytochem 54: 12151228.
  • 25
    Nakashima K, de Crombrugghe B 2003 Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 19: 458466.
  • 26
    Byun JH, Park BW, Kim JR, Lee JH 2007 Expression of vascular endothelial growth factor and its receptors after mandibular distraction osteogenesis. Int J Oral Maxillofac Surg 36: 338344.
  • 27
    Mori S, Akagi M, Kikuyama A, Yasuda Y, Hamanishi C 2006 Axial shortening during distraction osteogenesis leads to enhanced bone formation in a rabbit model through the HIF-1alpha/vascular endothelial growth factor system. J Orthop Res 24: 653663.
  • 28
    Harper J, Gerstenfeld LC, Klagsbrun M 2001 Neuropilin-1 expression in osteogenic cells: Down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 81: 8292.
  • 29
    Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW 2000 Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141: 16671674.
  • 30
    Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, Weich H 2005 Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: Autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95: 827839.
  • 31
    Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE 2002 Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30: 472477.
  • 32
    Orlandini M, Spreafico A, Bardelli M, Rocchigiani M, Salameh A, Nucciotti S, Capperucci C, Frediani B, Oliviero S 2006 Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation. J Biol Chem 281: 1796117967.
  • 33
    Tombran-Tink J, Barnstable CJ 2004 Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: Possible mediators of angiogenesis and matrix remodeling in the bone. Biochem Biophys Res Commun 316: 573579.
  • 34
    Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanaka M, Nagashima M, Nakamura T 2003 Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 32: 491501.
  • 35
    Otomo H, Sakai A, Uchida S, Tanaka S, Watanuki M, Moriwaki S, Niida S, Nakamura T 2007 2007 Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential. Bone 40: 14941501.
  • 36
    Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P 2002 Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt-1. Nat Med 8: 831840.
  • 37
    Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N 1999 VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623628.
  • 38
    Bluteau G, Julien M, Magne D, Mallein-Gerin F, Weiss P, Daculsi G, Guicheux J 2007 VEGF and VEGF receptors are differentially expressed in chondrocytes. Bone 40: 568576.
  • 39
    Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F 2000 Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: Auto-paracrine role during endochondral bone formation. J Cell Sci 113: 5969.
  • 40
    Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE 2002 Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30: 472477.
  • 41
    Fiedler J, Leucht F, Waltenberger J, Dehio C, Brenner RE 2005 VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334: 561568.
  • 42
    Peng H, Usas A, Olshanski A, Ho AM, Gearhart B, Cooper GM, Huard J 2005 VEGF improves, whereas sFlt-1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20: 20172027.
  • 43
    Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP 2006 VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20: 14951497.
  • 44
    Santos SC, Miguel C, Domingues I, Calado A, Zhu Z, Wu Y, Dias S 2007 VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing. Exp Cell Res 313: 15611574.
  • 45
    Bouletreau PJ, Warren SM, Spector JA, Peled ZM, Gerrets RP, Greenwald JA, Longaker MT 2002 Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: Implications for fracture healing. Plast Reconstr Surg 109: 23842397.
  • 46
    Jell G, Kerjaschki D, Revell P, Al-Saffar N 2006 Lymphangiogenesis in the bone-implant interface of orthopedic implants: Importance and consequence. J Biomed Mater Res A 77: 119127.
  • 47
    Bilic-Curcic I, Kalajzic Z, Wang L, Rowe DW 2005 Origins of endothelial and osteogenic cells in the subcutaneous collagen gel implant. Bone 37: 678687.
  • 48
    Hirao M, Tamai N, Tsumaki N, Yoshikawa H, Myoui A 2006 Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem 281: 3107931092.
  • 49
    Robins JC, Akeno N, Mukherjee A, Dalal RR, Aronow BJ, Koopman P, Clemens TL 2005 Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 37: 313322.
  • 50
    Malladi P, Xu Y, Chiou M, Giaccia AJ, Longaker MT 2007 Hypoxia inducible factor-1alpha deficiency affects chondrogenesis of adipose-derived adult stromal cells. Tissue Eng 13: 11591171.
  • 51
    Pfander D, Cramer T, Schipani E, Johnson RS 2003 HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 116: 18191826.